- Research
- Open access
- Published:
Polypharmacy among adults receiving outpatient care at Kitgum General Hospital, Northern Uganda
BMC Primary Care volume 26, Article number: 148 (2025)
Abstract
Background
Polypharmacy is a major safety concern, associated with adverse outcomes, higher health services utilization, and healthcare costs. However, there is limited data on polypharmacy in the outpatient settings in semi-urban primary care settings. We assessed the prevalence and factors associated with polypharmacy among adults receiving outpatient care at Kitgum General Hospital, Uganda.
Methods
We conducted a facility-based, cross-sectional study among adults receiving outpatient care at Kitgum General Hospital between October and December 2023. Polypharmacy was defined as the concurrent use of five or more medicines. Data was collected using a structured tool. A multivariable logistic regression analysis was performed to assess the factors associated with polypharmacy.
Results
A total of 422 participants, with a mean age of 43.0 ± 18.3 years were enrolled. More than a third of the participants (35.3%, n = 149) had chronic medical conditions. Overall, 43.4% (n = 183) (95% CI: 38.7–48.2) of the participants had polypharmacy. The majority were on antibiotics (91.8%, n = 168) and analgesics (77.6%, n = 142). In total, 145 (34.4%) reported use of over-the-counter drugs and 60 (14.2) used herbal medicines. Having a chronic illness (Adjusted Odds Ratio (aOR): 5.93, 95% CI: 3.10–11.34, p < 0.001), and use of over-the-counter drugs (aOR: 16.7; 95% CI: 8.87–31.42, p = 0.009) were associated with higher odds of polypharmacy. Herbal medicine use was associated with 64% lower odds of polypharmacy (aOR: 0.36; 95% CI: 0.17–0.77, p < 0.001).
Conclusion
Polypharmacy was observed in almost 2 in every 5 adults receiving outpatient care in Kitgum General Hospital. Chronic illness and use of over the counter medicines increased the odds of polypharmacy among adult outpatients. Priority should be put in place to mitigate polypharmacy among outpatients in Northern Uganda and similar low resource settings.
Background
Polypharmacy is commonly defined as the practice of concurrent use of five or more medications [1]. However, some complex patients with multi-morbidity and conditions such as heart failure, tuberculosis and human immunodeficiency virus (HIV) infection may benefit from polypharmacy as an appropriate guideline directed medical therapy [2]. While polypharmacy can be beneficial for these group of patients, it is also linked to increased healthcare costs, medication errors, hospitalization, and adverse health outcomes such as drug-drug interaction incidents, adverse drug reactions, increased risk of geriatric syndrome (such as falls, and fracture), low cognitive functions, renal impairment, sarcopenia, and hospitalization. Studies have shown that polypharmacy is one of the most significant factors that may lead to patients’ nonadherence to drugs [3,4,5]. Polypharmacy is an expensive practice, that results in a significant economic burden to the health care system and patients [6].
Polypharmacy is associated with increased clinic visits and rehospitalization, with an approximately 30% increase in medical costs [6, 7]. The worldwide prevalence of polypharmacy ranges from 10 to 90% depending on age, definition used, health care system and geographical setting [8]. In Sweden, 44% of people over 65 years had polypharmacy [9], 46% among outpatients in Saudi Arabia [10], and 56% among individuals aged 80 years or older in Poland [11]. A more recent study from South Africa found about 12 medicines prescribed on average to geriatric outpatients [12]. In Uganda, polypharmacy among older adults with HIV on anti-retroviral therapy (ART) was 15.3% [13]. In addition, a study in Uganda among inpatients with heart failure found the prevalence of adverse drug reactions at 56% and was highly associated with polypharmacy [14].
Studies from developed countries reports overweight, obesity, comorbidities, frailty, sex, and mental illness such as dementia and old age to be significantly associated with polypharmacy [3, 10]. Most studies on polypharmacy in Uganda focused on specific populations such as older people living with HIV, in patients with heart failure and other comorbidities [13, 14]. There is limited information on the prevalence and factors associated with polypharmacy among general adult outpatients in Uganda. Therefore, we aimed to determine the prevalence and factors associated with polypharmacy among adults receiving outpatient care at Kitgum General Hospital, Kitgum district, Northern Uganda.
Methods
Study design and setting
Between October and December 2023, we conducted a healthcare facility-based, cross-sectional study among adults receiving outpatient care at the outpatient department (OPD) of Kitgum General Hospital, a public hospital located in Kitgum District, Northern Uganda.
Study population
Participants in this study were adults aged 18 years and above, receiving outpatient care at Kitgum General Hospital during the study period. Patients who were critically ill or required immediate medical attention, as determined by healthcare providers were excluded. A sampling frame was made. The study participants were obtained by systematic sampling. The first participant was recruited after tossing a coin and obtaining the head. The subsequent participant was recruited after every 5 th adult patient until required sample size reached.
Sample size
The sample size was calculated using the survey formula by Kish Leslie (1965);
where z = z value at 95% confidence interval = 1.96.
P = Proportion of 50% (0.5) was used since prevalence of polypharmacy among adults receiving outpatient care in Uganda is unknown.
d = Precision/acceptable error (0.05)
= 384.16, Factoring in a non-response rate of 10% gives a final minimum sample size of 422 participants.
Data collection
The questionnaire used was adapted from previous studies on polypharmacy [10, 13, 15] to capture the specific context of outpatient care at Kitgum General Hospital and pretested but the participants were not used in the study. In addition, questionnaire was translated into Acholi language and back translated to English. The tool captured information on the different number of medicines a person is on in a day. Additional data included demographic characteristics such as age, sex, obesity, comorbidities, educational level and so on. The study tool was administered by trained research assistants who are nurses working in the OPD. The questionnaires were administered face-to-face by the research assistants who explained the purpose of the study and ensured confidentiality of responses. Data collection was conducted in a private and comfortable room to encourage open and honest responses.
Variables
The outcome variable polypharmacy was defined as concurrent use of five or more medicines (1). Independent variables included socio-demographics characteristics; age, sex, body mass index (BMI), smoking, use of over-the-counter drugs and educational level, medical factors; chronic conditions (for example hypertension, diabetes mellitus), hospitalization, and other comorbidities, health system-related factors; cadre and experience of the prescriber.
Statistical analysis
Data was analyzed using STATA software version 15.0. Categorical variables were summarized as frequencies and percentages and continuous variables were expressed in terms of mean and standard deviation for normally distributed variables or median and interquartile range for non-normally distributed variables. All analyses were two-tailed, set at a 95% confidence interval (95% CI) and a p < 0.05 was considered statistically significant. The prevalence of polypharmacy was determined by dividing the number of participants taking five or more drugs currently by the total participants and the finding expressed as a percentage. To determine factors associated with polypharmacy, we conducted both bivariable and multivariable analyses.
Simple logistic regression was performed for bivariable data analysis and results presented as crude odds ratios (cOR) with corresponding CIs and p-values. Variables with p < 0.2 at bivariable analysis and biologically plausible factors such as old age were forwarded to logistic regression models for multivariable analysis. Before running the multivariable logistic regression, we checked the variables for multicollinearity using variance inflation factor (VIF) analysis with variables having VIF > 10 considered to have collinearity. There was no multicollinearity among the variables with the highest VIF of 5.48 for marital status, followed by 4.89 for number of OPD visits in the last 12 months to the time of data collection. We entered the independent variables at the beginning step of the model building. Utilizing a stepwise, backward elimination method, we subsequently, removed each factor with the least p-value while testing the model fit using the goodness-of-fit test [16] to obtain the best-fit model. Multivariable analysis results were reported using the adjusted odds ratios (aOR), with corresponding 95% CI and p-values.
Results
Socio-demographic characteristics of the participants
A total of 422 participants were enrolled. More than two-thirds (68.5%, n = 289) were females and 61.6% (n = 260) were married. The mean age ± Standard Deviation of all the participants was 43.0 ± 18.3 years. More than half (52.6%, n = 222) were unemployed and 57.8% (n = 244) had an average monthly income of less than 120,000 Uganda Shilling (32.4 US Dollar) (Table 1).
Clinical characteristics of adults receiving outpatient care at Kitgum General Hospital
Slightly more than a third of the participants (35.3%, n = 149) had a chronic medical condition. Among those with chronic medical conditions, the majority had hypertension (38.3%, n = 57) and followed by diabetes mellitus (17.5%, n = 26). Majority of the participants (61.4%, n = 259) had visited OPD three times or more in the last 12 months. More than two-thirds (84.6%, n = 357) received a prescription for medicines whenever they came for consultation in OPD. 14.2% of the participants reported intake of herbal medicine in the last 6 months and two-thirds 66.4% of the participants had normal BMI and only 2.1% were obese (Table 2). Less than a tenth (8.8%, n = 37) reported experiencing side effects and more than half (66.6%, n = 281) received the prescriptions from a clinical officer. Slightly more than a third (34.4%, n = 145) of the participants reported use of over-the-counter drugs (Table 3).
Factors associated with polypharmacy among adults receiving outpatient care at Kitgum General Hospital, Uganda
Results from bivariable analysis indicated that several factors had significant associations with polypharmacy. Factors that showed positive associations with polypharmacy included: older age group > 65 years (p < 0.001), widowed (p < 0.001), having a chronic illness (p < 0.001), having had hospitalization in the last 12 months (p < 0.005), having BMI > 30 that is obese adults (p < 0.02), having had 3 or more OPD visits in the last 6 months (p < 0.01) and use of over-the-counter drugs (p < 0.001). At the multivariable level after controlling for several polypharmacy-related variables, factors associated with polypharmacy include; having a chronic illness (AOR: 5.93 95% CI: 3.10–11.34, p < 0.001), use of over-the-counter drugs (AOR: 16.7; 95% CI: 8.87–31.42, p < 0.001) and herbal medicine intake (AOR: 0.36; 95% CI: 0.17–0.77, p = 0.009). The odds of polypharmacy among participants with chronic illnesses were 5.93 times higher than that among adult outpatients without chronic illness, participants who were taking over-the-counter drugs had 16.7 times higher odds of polypharmacy compared to those not using over-the-counter drugs and the participants who were taking herbal medicines had 64% lower risk of polypharmacy than adults not taking herbal medicines (Table 4).
Medicine intake and factors influencing polypharmacy among adults receiving outpatient care at Kitgum General Hospital, Uganda
In total, 183 (43.4%; 95% CI: 38.7–48.2) participants had polypharmacy. Among the participants who had polypharmacy, most were taking antibiotics (91.8%, n = 168), analgesics (77.6%, n = 142), antiallergics, (33.3%, n = 61), antihypertensives (31.7%, n = 58), supplements (29.0%, n = 53), antiacids (24.0%, n = 44), and antidiabetics (17.5%, n = 32) (Fig. 1). Most reported over-the-counter drugs used were analgesics (40.0%, n = 58), antibiotics (36.6%, n = 53), antimalarials (24.8%, n = 36), antiallergics (23.4%, n = 34), and supplements (18.6%, n = 27) (Fig. 2). Most of the participants (n = 160) disagree that the healthcare providers explained the purpose and potential side effects of medicine, (n = 173) agree that they feel comfortable discussing their medication regiments and concern with their healthcare provider, (n = 228) disagree that sometime they request specific medications and (n = 161) disagree that they have missed taking their medication (Fig. 3).
Discussion
The prevalence of polypharmacy in this study was high at 43.4%. The factors associated with polypharmacy were, having a chronic illness, use of over-the-counter drugs and herbal medicine use. The prevalence of polypharmacy of 43.4% in our study is comparable to reported studies done in Sweden among patients > 65 years of age [9] and in Saudi Arabia among outpatients [10] which found prevalence of polypharmacy at 44% and 46% respectively. This observed similarity could be because all these studies were done among only the outpatients. However, our finding is lower than that reported from a study in Poland among elderly patients > 80 years [11] which revealed that 56% of the elderly patients were receiving polypharmacy prescriptions. Our finding is also lower than a study done in South Africa [12] which showed about 12 medicines prescribed on average to geriatric outpatients. The observed difference could be because most elderly patients have one or more comorbidities hence at high risk of polypharmacy as compared to our study population which included all adult outpatients aged 18 years and above. Furthermore, elderly patients always see more than one Physician due to their comorbidities hence at risk of receiving multiple prescriptions [17]. Interestingly, the prevalence of polypharmacy in our study was higher than that of a previous study among adult outpatients over 50 years with HIV in an urban clinic, Kampala Uganda [13], which reported a prevalence of 15.3%. This observed difference could be because in our study the participants were sick patients who had come to get medical care however, in the study done among people with HIV in Kampala, Uganda, most of the clients were not sick and they had gone just for the refill of their ART and secondly, the study population were also difference from our study population. Additionally, we also accounted for any ongoing medicines the participant was taking.
Furthermore, our study findings showed that among adults who had polypharmacy, 91.8% were taking antibiotics and 77.6% were taking analgesics. Also, over 34.4% were taking over-the-counter drugs. These findings are comparable with a study in Eastern Uganda [18]. In addition, this polypharmacy may predispose them to medication errors, hospitalization, and adverse health outcomes such as drug-drug interaction incidents, adverse drug reactions, increased risk of geriatric syndrome, low cognitive functions, renal impairment, sarcopenia, hospitalization and nonadherence to drugs [3,4,5].
This study found polypharmacy more common among participants with chronic illnesses. This could be because adult outpatients who have chronic illnesses may have multiple medical complications, and their management requires the use of multiple medications to control the disease. Our finding is consistent with similar literature findings which found that patients with more than one chronic condition especially the elderly require the use of multiple drug therapies leading to potential medical-related issues like adverse drug reactions, poor adherence, and drug-drug interactions [10, 13, 19, 20]. Therefore, a careful and regular review of patient’s medications would be important in population to minimize the risk of polypharmacy [21]. Another factor that might have led to polypharmacy among outpatients with chronic illnesses is that we conducted the study in a public facility where patients receive medications free of charge. Studies have shown that medication cost is a known factor that decreases consumption of medications and is associated with a negative impact on adherence [22]. In addition, participants who were taking over-the-counter drugs had higher odds of polypharmacy. This could be because outpatients who were taking over-the-counter drugs bought from private pharmacy may take them concurrently with the prescribed medicines from the hospital hence at risk of polypharmacy. This is consistent with a study done by Votova and colleagues who found that 20% of Canadian adults had a high probability of using prescribed medications and over-the-counter drugs concurrently [23]. Interestingly, the participants who were taking herbal medicines had lower risk of polypharmacy. Therefore, we postulate the need for further research on the relationship between herbal medicines and polypharmacy since our study has shown some protective relationship.
Our findings emphasize the need for healthcare providers to assess medication prescription regularly and carefully, especially among patients with chronic illnesses. Also, prescription guidelines and disciplines among healthcare workers should be enforced. In addition, there is need to increase public awareness about the danger of the use of over-the-counter drugs without prescription, emphasizing outcomes like medical cost, adverse drug reactions, drug-drug interactions, and drug-food interactions.
Strengths and limitations
The study site receives patients from more than one district hence a good representative of the study population in both rural and urban settings. Pretesting of questionnaire provided clarity of the questions and increased the response rate. In addition, training of the research assistants provided skills which enabled the research assistants to collect data with the highest skills and ethical standards. Finally, the ample sample size used made it representative of the study population and the response rate of 100% minimized selection bias thus enhancing the generalizability of the research findings. The main limitation of the study lies in its cross-sectional design that restrict the ability to establish causal relationships. Moreover, the study site is a government public facility which may not reflect reality in private not-for-profit and private for-profit facilities in Uganda. Further research in diverse settings and populations is needed to ensure the broader applicability of the study findings. There could be recall bias.
Conclusions
The prevalence of polypharmacy among adult outpatients at Kitgum General Hospital was high. Chronic illness, use of over-the-counter drugs and intake of herbal medicines have a significant impact on polypharmacy among adult outpatients at Kitgum General Hospital, Uganda. Special attention is required to mitigate the apparent high prevalence of polypharmacy among adult outpatients with emphasis on those who have chronic illnesses, using over-the-counter medicines and accompany use of herbal medicines. Prescription guidelines and disciplines among healthcare workers should be enforced and a study on the relationship between herbal medicine and polypharmacy is recommended.
Data availability
Data is provided within the manuscript or supplementary information files.
References
Masnoon N, Shakib S, Kalisch-Ellett L, Caughey GE. What is polypharmacy? A systematic review of definitions. BMC Geriatr. 2017;17(1):230. https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s12877-017-0621-2.
Hughes C. Appropriate and inappropriate polypharmacy—Choosing the right strategy. Br J Clin Pharmacol. 2021;87(1):84–6. https://doiorg.publicaciones.saludcastillayleon.es/10.1111/bcp.14589.
Haider SI, Ansari Z, Vaughan L, Matters H, Emerson E. Prevalence and factors associated with polypharmacy in Victorian adults with intellectual disability. Res Dev Disabil. 2014;35(11):3071–80. https://doiorg.publicaciones.saludcastillayleon.es/10.1016/j.ridd.2014.07.060.
Davies LE, Spiers G, Kingston A, Todd A, Adamson J, Hanratty B. Adverse Outcomes of Polypharmacy in Older People: Systematic Review of Reviews. J Am Med Dir Assoc. 2020;21(2):181–7. https://doiorg.publicaciones.saludcastillayleon.es/10.1016/j.jamda.2019.10.022.
Wastesson JW, Morin L, Laroche M, Johnell K. How Chronic Is Polypharmacy in Old Age? A Longitudinal Nationwide Cohort Study. J Am Geriatr Soc. 2019;67(3):455–62. https://doiorg.publicaciones.saludcastillayleon.es/10.1111/jgs.15717.
Kojima G, Bell C, Tamura B, Inaba M, Lubimir K, Blanchette PL, Iwasaki W, Masaki K. Reducing Cost by Reducing Polypharmacy: The Polypharmacy Outcomes Project. J Am Med Dir Assoc. 2012;13(9):818.e11–818.e15. https://doiorg.publicaciones.saludcastillayleon.es/10.1016/j.jamda.2012.07.019.
Maher RL, Hanlon J, Hajjar ER. Clinical consequences of polypharmacy in the elderly. Expert Opin Drug Saf. 2014;13(1):57–65. https://doiorg.publicaciones.saludcastillayleon.es/10.1517/14740338.2013.827660.
Khezrian M, McNeil CJ, Murray AD, Myint PK. An overview of prevalence, determinants and health outcomes of polypharmacy. Therapeutic Advances in Drug Safety. 2020;11:204209862093374. https://doiorg.publicaciones.saludcastillayleon.es/10.1177/2042098620933741.
Morin L, Calderon Larrañaga A, Welmer A-K, Rizzuto D, Wastesson J, Johnell K. <p>Polypharmacy and injurious falls in older adults: a nationwide nested case-control study</p>. Clin Epidemiol. 2019;11:483–93. https://doiorg.publicaciones.saludcastillayleon.es/10.2147/CLEP.S201614.
Balkhi B, AlQahtani N, Alwhaibi M, Alshammari TM, Alhawassi TM, Mahmoud MA, Almetwazi M, Ata S, Basyoni M, Aljadhey H. Prevalence and Factors Associated With Polypharmacy Use Among Adult Patients in Saudi Arabia. J Patient Saf. 2021;17(8):e1119–24. https://doiorg.publicaciones.saludcastillayleon.es/10.1097/PTS.0000000000000439.
Kardas, P., Urbański, F., Lichwierowicz, A., Chudzyńska, E., Kardas, G., & Czech, M. (2021). Prevalence and Age Structure of Polypharmacy in Poland: Results of the Analysis of the National Real-World Database of 38 Million Citizens. Frontiers in Pharmacology, 12. https://doiorg.publicaciones.saludcastillayleon.es/10.3389/fphar.2021.655364
Bojuwoye AO, Suleman F, Perumal-Pillay VA. Polypharmacy and the occurrence of potential drug-drug interactions among geriatric patients at the outpatient pharmacy department of a regional hospital in Durban, South Africa. Journal of Pharmaceutical Policy and Practice. 2022;15(1):1. https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s40545-021-00401-z.
Ssonko M, Stanaway F, Mayanja HK, Namuleme T, Cumming R, Kyalimpa JL, Karamagi Y, Mukasa B, Naganathan V. Polypharmacy among HIV-positive older adults on anti-retroviral therapy attending an urban clinic in Uganda. BMC Geriatr. 2018;18(1):125. https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s12877-018-0817-0.
Shegena EA, Nigussie KA, Tamukong R, Lumori BAE, Yadesa TM. Prevalence and factors associated with adverse drug reactions among heart failure patients hospitalized at Mbarara Regional Referral Hospital. Uganda BMC Cardiovascular Disorders. 2022;22(1):480. https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s12872-022-02937-7.
Castioni J, Marques-Vidal P, Abolhassani N, Vollenweider P, Waeber G. Prevalence and determinants of polypharmacy in Switzerland: data from the CoLaus study. BMC Health Serv Res. 2017;17(1):840. https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s12913-017-2793-z.
Akaike, H. (2011). Akaike’s information criterion. International encyclopedia of statistical science, 25–25.
Gibson TB, R. J. O. The effects of prescription drug cost sharing: A review of the evidence. American Journal of Managed Care. 2005;11(11):11.
Obakiro SB, Napyo A, Wilberforce MJ, Adongo P, Kiyimba K, Anthierens S, Kostyanev T, Waako P, van Royen P. Are antibiotic prescription practices in Eastern Uganda concordant with the national standard treatment guidelines? A cross-sectional retrospective study. Journal of Global Antimicrobial Resistance. 2022;29:513–9. https://doiorg.publicaciones.saludcastillayleon.es/10.1016/j.jgar.2021.11.006.
Al-Dahshan A, Al-Kubiasi N, Al-Zaidan M, Saeed W, Kehyayan V, Bougmiza I. Correction: Prevalence of polypharmacy and the association with non-communicable diseases in Qatari elderly patients attending primary healthcare centers: A cross-sectional study. PLoS ONE. 2020;15(8): e0238343. https://doiorg.publicaciones.saludcastillayleon.es/10.1371/journal.pone.0238343.
Mohsenzadeh P, Ardekani A, Poustchi H, Mohammadi Z, Abdipour Mehrian SR, Bazrafshan Drissi H, Rahimian Z, Taherifard E, Nabavizadeh A, kamalipour, A., Mesgarpour, B., Malekzadeh, F., & Molavi Vardanjani, H. Population-based pattern of medication use and prevalence of polypharmacy among patients with cardiovascular diseases: results of the Pars cohort study from Iran. BMC Cardiovasc Disord. 2022;22(1):435. https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s12872-022-02872-7.
Rijal, S. (2022). Polypharmacy in Elderly People: A Simple Review. Journal of Pharmaceutical Research International, 40–49. https://doiorg.publicaciones.saludcastillayleon.es/10.9734/jpri/2022/v34i647293
Schoen C, Osborn R, Squires D, Doty M, Pierson R, Applebaum S. New 2011 Survey Of Patients With Complex Care Needs In Eleven Countries Finds That Care Is Often Poorly Coordinated. Health Aff. 2011;30(12):2437–48. https://doiorg.publicaciones.saludcastillayleon.es/10.1377/hlthaff.2011.0923.
Votova, K., Blais, R., Penning, M. J., & Maclure, M. K. (2013). Polypharmacy Meets Polyherbacy: Pharmaceutical, Over-the-counter, and Natural Health Product Use Among Canadian Adults. Canadian Journal of Public Health, 104(3), e222–e228. https://doiorg.publicaciones.saludcastillayleon.es/10.17269/cjph.104.3
Acknowledgements
We acknowledge the study participants, the administration of Kitgum General Hospital and the Department of Public Health of Gulu University.
Funding
There was no funding toward research study.
Author information
Authors and Affiliations
Contributions
N.O, D.M and F.B; Conceptualization of the study protocol, N.O, D.M and F.B designed the study, N.O data collection, N.O and R.N did data analysis, N.O, D.M, J.J.L, J.O and F.B wrote the main manuscript. All the authors have revised and approved the submitted version of the manuscript.
Corresponding author
Ethics declarations
Ethics approval and consent to participate
The study protocol was approved by the Gulu University Research Ethics Committee (GUREC reference no: GUREC-2023–592). Administrative clearance from Kitgum General Hospital was obtained. Written informed consent was obtained from all participants. Ethical regulations outlined in the Declaration of Helsinki were observed throughout the study. Anonymity was guaranteed during data collection to ensure confidentiality and encourage honest responses. No participant identifiable characteristics beyond basic demographics were collected.
Consent for publication
Not applicable.
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.
About this article
Cite this article
Oyoo, N., Musoke, D., Nantale, R. et al. Polypharmacy among adults receiving outpatient care at Kitgum General Hospital, Northern Uganda. BMC Prim. Care 26, 148 (2025). https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s12875-025-02863-5
Received:
Accepted:
Published:
DOI: https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s12875-025-02863-5